The estimated Net Worth of Thomas K. Equels is at least $142,454.58. Thomas K. Equels owns over 811,707 units of Hemispherx Biopharma, Inc. stock worth over $142,454.58.
| Transaction Date | Company | Shares | Type | Owned | Price | Value | Post Value |
|---|---|---|---|---|---|---|---|
| 27th February 2019 | HEB - Hemispherx Biopharma, Inc. | 325,000 | Exercise of in-the-money or at-the-money derivatives securities (usually options) | 325,000 | $0.00 | ||
| 27th February 2019 | HEB - Hemispherx Biopharma, Inc. | 65 | Exercise of in-the-money or at-the-money derivatives securities (usually options) | 65 | $0.00 | ||
| 19th March 2019 | HEB - Hemispherx Biopharma, Inc. | 13,400 | Open or private purchase | 811,707 | $0.18 | $2,351.70 | $142,454.58 |
| 8th May 2019 | HEB - Hemispherx Biopharma, Inc. | 227,500 | Conversion of derivative | 1,364,207 | $0.00 | ||
| 18th March 2019 | HEB - Hemispherx Biopharma, Inc. | 325,000 | Conversion of derivative | 1,136,707 | $0.00 | ||
| 21st June 2019 | HEB - Hemispherx Biopharma, Inc. | 29,404 | Open or private purchase | 1,393,611 | $4.03 | $118,498.12 | $5,616,252.33 |
| 27th June 2019 | HEB - Hemispherx Biopharma, Inc. | 2,632 | Open or private purchase | 63,041 | $4.37 | $11,501.84 | $275,489.17 |
| 15th October 2019 | HEB - Hemispherx Biopharma, Inc. | 13,470 | Grant/award etc. | 76,511 | $0.58 | $7,812.60 | $44,376.38 |
| 31st October 2019 | HEB - Hemispherx Biopharma, Inc. | 15,625 | Grant/award etc. | 92,136 | $0.50 | $7,812.50 | $46,068.00 |
| 15th November 2019 | HEB - Hemispherx Biopharma, Inc. | 16,622 | Grant/award etc. | 108,758 | $0.47 | $7,812.34 | $51,116.26 |
| 29th November 2019 | HEB - Hemispherx Biopharma, Inc. | 19,531 | Grant/award etc. | 128,289 | $0.40 | $7,812.40 | $51,315.60 |
| 13th December 2019 | HEB - Hemispherx Biopharma, Inc. | 17,960 | Grant/award etc. | 146,249 | $0.44 | $7,812.60 | $63,618.32 |
| 31st December 2019 | HEB - Hemispherx Biopharma, Inc. | 14,741 | Grant/award etc. | 160,990 | $0.53 | $7,812.73 | $85,324.70 |
| 21st August 2020 | HEB - Hemispherx Biopharma, Inc. | 10,730 | Open or private purchase | 171,717 | $2.33 | $25,000.90 | $400,100.61 |
| 3rd September 2020 | HEB - Hemispherx Biopharma, Inc. | 12,316 | Open or private purchase | 184,033 | $2.03 | $25,001.48 | $373,586.99 |